CSL Investor Relations Material
Latest events
H1 2025
CSL
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CSL Limited
Access all reports
CSL Limited is a global biotechnology company specializing in the development and manufacture of products that treat serious human medical conditions. It operates across segments such as biotherapies, vaccines, and plasma protein therapies, serving the healthcare sector. CSL provides critical biological medicines to healthcare providers worldwide through its research, development, and manufacturing operations. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Key slides for CSL Limited
Shareholder Briefing
CSL Limited
Shareholder Briefing
CSL Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CSL
Country
🇦🇺 Australia